Cell-Based Gel May Improve Survival of Bioengineered Tissues A biologically engineered gel designed to improve the survival of bioengineered organs and other tissues has shown promise in early laboratory testing, according to researchers. [Press release from the American College of Surgeons discussing research presented at the 2011 Annual Clinical Congress of the American College of Surgeons, San Francisco] Press ReleaseSurgeons Successfully Regenerate Tissue-Engineered Small Intestine from Frozen Intestinal Cells Researchers were able to successfully isolate and store organoid units and later generate tissue-engineered small intestine in a mouse model. [Press release from Newswise discussing research presented at the 2011 Annual Clinical Congress of the American College of Surgeons, San Francisco] Press Release Surgeons Develop Simultaneous Tissue and Stem Cell Transplant Technique Surgical researchers have pioneered a method using stem cells that may one day eliminate the need for antirejection drugs in transplants. [Press release from Newswise discussing research presented at the 2011 Annual Clinical Congress of the American College of Surgeons, San Francisco] Press Release Herpes Virus Shows Early Promise In Treating Triple-Negative Breast Cancer Researchers report they have successfully treated triple-negative breast cancer in petri dishes and in mouse models with a method based upon a herpes simplex virus. [Press release from Newswise discussing research presented at the 2011 Annual Clinical Congress of the American College of Surgeons, San Francisco] Press Release Geron Announces Presentation at ECTRIMS/ACTRIMS Geron Corporation announced data on the use of GRNOPC1, oligodendrocyte progenitors derived from human embryonic stem cells, for myelin repair in a non-human primate model. [Press release from Geron Corporation discussing research presented at the 5th Joint Triennial Congress of the European and Americas Committees for Treatment and Research in Multiple Sclerosis, Amsterdam] Press Release A New Hope for Patients with HIV When an HIV-positive patient with leukemia received an experimental hematopoietic stem cell therapy to treat his cancer, something surprising occurred: the treatment also removed all traces of HIV from his blood. [Press release from the American Association of Blood Banks (AABB) discussing research presented at the AABB Annual Meeting & CTTXPO 2011, San Diego] Press Release TxCell Presents Final Positive Results of the Phase I/II Clinical Trial with Antigen-Specific Regulatory T Cells in Crohn’s Disease TxCell SA announces the presentation of final positive results of the phase I/II study in Crohn’s disease (CATS-1) with its leading product candidate, OvaSave®. [Press release from TxCell SA discussing research presented at the United European Gastroenterology Week, Stockholm] Press Release Using Gene Therapy to Make Thyroid Tumors More Susceptible to Radioiodine Therapy Using a non-viral gene delivery system based on nanoparticle vectors, researchers are able to introduce the gene for the sodium iodide symporter into radioiodine-refractory tumor cells, enhancing their uptake of therapeutic radioiodine. [Press release from Newswise discussing research presented at the 81st Annual Meeting of the American Thyroid Association, Indian Wells] Press Release Neuralstem Receives FDA Approval to Dose Patients in Cervical Region in Ongoing ALS Trial Neuralstem, Inc. announced that, after reviewing safety data from the first 12 patients, the Food and Drug Administration (FDA) has granted approval for the trial to advance to transplanting patients in the cervical region. [Neuralstem, Inc.] Press Release First Patient Receives Novel Gene Therapy for Type of Blindness The first patient to receive gene therapy for an incurable type of blindness was treated at the John Radcliffe Hospital in Oxford as part of a trial led by Oxford University. [University of Oxford] Press Release
|